COMMODORE CAPITAL LP 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | C4 Therapeutics, Inc. CCCC | COMMODORE CAPITAL LP | 3,410,384 4.800% | -389,616 (-10.25%) | Filing |
| 2023-12-22 4:05 pm Purchase | 2023-12-14 | 13G | C4 Therapeutics, Inc. CCCC | COMMODORE CAPITAL LP | 3,800,000 7.700% | 3,800,000 (New Position) | Filing |